<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://whdc.ac/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=CarinPatino726</id>
	<title>WHDC Academics - User contributions [en]</title>
	<link rel="self" type="application/atom+xml" href="https://whdc.ac/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=CarinPatino726"/>
	<link rel="alternate" type="text/html" href="https://whdc.ac/index.php/Special:Contributions/CarinPatino726"/>
	<updated>2026-05-26T05:07:18Z</updated>
	<subtitle>User contributions</subtitle>
	<generator>MediaWiki 1.43.5</generator>
	<entry>
		<id>https://whdc.ac/index.php?title=4F-MDMB-BINACA_Wikipedia&amp;diff=209596</id>
		<title>4F-MDMB-BINACA Wikipedia</title>
		<link rel="alternate" type="text/html" href="https://whdc.ac/index.php?title=4F-MDMB-BINACA_Wikipedia&amp;diff=209596"/>
		<updated>2026-05-21T07:02:30Z</updated>

		<summary type="html">&lt;p&gt;CarinPatino726: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. It is illegal to sell, distribute, supply, transport or trade the pharmaceutical drug under the Psychoactive Substances Act 2016. The corresponding indole core analogue, 4F-MDMB-BICA (4F-MDMB-BUTICA), has also been widely sold as a designer drug by chemical providers on the internet, first being identified in May 2020. It has been used as an active ingredient in synthetic cannabis products and sold as a designer drug since late 2018. 4F-MDMB-BINACA (also known as MDMB-4F-BINACA using systematic EMCDDA nomenclature or 4F-MDMB-BUTINACA) is an indazole-based synthetic cannabinoid from the indazole-3-carboxamide family.&amp;lt;br&amp;gt;Fig. &amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Fig. 2. &amp;lt;br&amp;gt;Separation of compounds was performed on a 2.1 mm×100 mm, 1.7 [https://cannabinoidsrc4f-adb.com/ 4F ADB] μm particle size ACQUITY Torus™ DIOL analytical column (Waters) with guard cartridge. Measurements were performed by an ACQUITY UPC2 supercritical fluid chromatography system (Waters) coupled with a Xevo TQ-S Triple Quadrupole Mass Spectrometer (Waters). During the death scene examination, multiple cigarette butts without filters were found in an ashtray; also found were alcohol bottles, an unopened box of nebivolol-containing drug, and 18 g of unrecognizable herbal residue in a cigarette box.&amp;lt;br&amp;gt;Victim B also brought &amp;quot;something resembling a drug&amp;quot; (unrecognizable by Witness A) from his cousin (Witness B) in a cigarette box and mixed this substance with their tobacco. The half-maximal effective concentration (EC50) of 4F-MDMB-BINACA is 5.69 nM (2.76–11.0 nM) on CB1, and 0.69 nM (0.30–1.56 nM) on CB2, in vitro half-life (t1/2) is 10.27 min . It is usually available as a powder, liquid (vapor fluid), or herbal plant mixtur&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Acute kidney damage and even kidney failure have been reported following use of synthetic cannabinoids (Davidson, et al., 2017). One recent study has looked at other mechanisms of action in some of the older synthetic cannabinoids and reported that some produced varying amounts of activity at sites which are related to cardiotoxicity and heart disease (Wiley et al., 2016). It is not known whether the increased toxicity is due only to activation of CB1 cannabinoid receptors more strongly than Δ9-THC or whether these &amp;quot;super-strength&amp;quot; cannabinoids produce effects at other receptors. A major cause of concern is that some of the more recently seen synthetic cannabinoids are more likely to produce extremely toxic effects than the older synthetics (Tai and Fantegrossi, 2017&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Thirty minutes prior to the training sessions, rats received an injection of either vehicle or Δ9-THC and were subsequently placed in the behavior-testing chambers, where food (45-mg food pellets; Bio-Serve, Frenchtown, NJ) was available as a reinforcer for every ten responses (FR10) on a designated injection appropriate lever. A houselight was centered over the hopper close to the ceiling and was illuminated only when the levers were active. Each dose range included doses that were without effect to those producing at least 50% depression compared to vehicle control. Twenty-four male Sprague-Dawley rats were obtained from Envigo (Houston, TX). 4F ADB Male ND4 Swiss–Webster mice were obtained from Envigo (Houston, TX) at approximately 8 weeks of age and maintained in the University of North Texas Health Science Center (UNTHSC) animal facility for two weeks prior to testin&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Figure 1. &amp;lt;br&amp;gt;Each training session lasted a maximum of 10 min, and the rats could earn up to 20 food pellets. Thirty minutes prior to the training sessions, rats received an injection of either vehicle or Δ9-THC and were subsequently placed in the behavior-testing chambers, where food (45-mg food pellets; Bio-Serve, Frenchtown, NJ) was available as a reinforcer for every ten responses (FR10) on a designated injection appropriate lever. A houselight was centered over the hopper close to the ceiling and was illuminated only when the levers were active. Each dose range included doses that were without effect to those producing at least 50% depression compared to vehicle control. Twenty-four male Sprague-Dawley rats were obtained from Envigo (Houston, TX). Male ND4 Swiss–Webster mice were obtained from Envigo (Houston, TX) at approximately 8 weeks of age and maintained in the University of North Texas Health Science Center (UNTHSC) animal facility for two weeks prior to testin&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Some mice showed abnormal behaviors (catalepsy, loss of traction, convulsion) right after the administration of the tested substances. The locomotor activity of the mice was measured 30 min and 2 hrs after the last substance administration. We also examined their neurotoxicity using brain samples through histopathological diagnose, especially in the nucleus accumbens core region. In histopathological analysis, neural cells of the animals treated with the high dose (5 mg/kg) of JWH-081 or JWH-210 showed distorted nuclei and nucleus membranes in the core shell of nucleus accumbens, suggesting neurotoxicity.&amp;lt;br&amp;gt;Table of Conten&lt;/div&gt;</summary>
		<author><name>CarinPatino726</name></author>
	</entry>
	<entry>
		<id>https://whdc.ac/index.php?title=User:CarinPatino726&amp;diff=209595</id>
		<title>User:CarinPatino726</title>
		<link rel="alternate" type="text/html" href="https://whdc.ac/index.php?title=User:CarinPatino726&amp;diff=209595"/>
		<updated>2026-05-21T07:02:21Z</updated>

		<summary type="html">&lt;p&gt;CarinPatino726: Created page with &amp;quot;Nuclear Power Engineer Briney Klejin, hailing from Sainte-Genevieve enjoys watching movies like The Derby Stallion and Lockpicking. Took a trip to Historic Centre of Mexico City and Xochimilco and drives a McLaren F1 GTR Longtail.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Here is my site; [https://cannabinoidsrc4f-adb.com/ 4F ADB]&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Nuclear Power Engineer Briney Klejin, hailing from Sainte-Genevieve enjoys watching movies like The Derby Stallion and Lockpicking. Took a trip to Historic Centre of Mexico City and Xochimilco and drives a McLaren F1 GTR Longtail.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Here is my site; [https://cannabinoidsrc4f-adb.com/ 4F ADB]&lt;/div&gt;</summary>
		<author><name>CarinPatino726</name></author>
	</entry>
</feed>